IP Library › Granted Patent US 8,722,723
Granted Patent B2
US 8,722,723 · App. 12/919,267 · Granted May 13, 2014

Aromatic amide derivative

Inventors: Nobuko Fujimaki (Tokyo, JP); Madoka Nakagomi (Kanagawa, JP); Koichi Shudo (Tokyo, JP)
Assignee: Research Foundation Itsuu Laboratory
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,722,723
App. No.
12/919,267
Granted
May 13, 2014
Kind
B2
Abstract

A compound represented by the following general formula (I) (R 1 and R 2 represent hydrogen atom, an alkyl group, a halogen atom, etc.; R 3 and R 4 represent hydrogen atom, an alkyl group, an alkoxy group, or an alkenyl group; R 5 represents hydrogen atom, an alkyl group, or nitro group, and R 6 represents hydrogen atom or an alkyl group), which acts on the transcription process of genes.

Claims (12)

1. A compound of formula (I) or a salt thereof:

wherein R 1 represents a group selected from the group consisting of a halogen atom, an amino group, or a mono- or dialkyl-substituted amino group;

R 2 represents a hydrogen atom;

R 3 represents a 3-carboxy-1-propyl group wherein the carboxyl group may form an ester;

R 4 represents a hydrogen atom; and

R 5 and R 6 bind together to become a methylene group (—CH 2 —) and thereby form a 5-membered ring.

2. 4-[4-(6-Dimethylamino-1-oxo-1,3-dihydro-isoindol-2-yl)-phenyl]-butyric acid or an alkyl ester thereof, 4-[4-(6-fluoro-1-oxo-1,3-dihydro-isoindol-2-yl)-phenyl]-butyric acid or an alkyl ester thereof, or 4-[4-(6-dimethylamino-1-oxo-1,3-dihydro-isoindol-2-yl)-phenyl]-butyric acid or an alkyl ester thereof.

3. 6-Dimethylamino-2-(4-propyl-phenyl)-isoindol-1-one, 5-dimethylamino-2-(4-cyclohexyl-phenyl)-isoindol-1-one, or 7-dimethylamino-2-(4-methoxyphenyl)-2,3-dihydro-isoindol-1-one.

4. A composition for inhibiting luciferase activity, which comprises the compound of formula (I) or a salt thereof according to claim 1 .

5. A composition for inhibiting luminescence for a bioluminescence system containing a luciferase and luciferin, which comprises the compound of formula (I) or a salt thereof according to claim 1 .

6. A method for inhibiting luciferase activity, which comprises contacting the compound of formula (I) or a salt thereof according to claim 1 with luciferase.

7. A method for inhibiting luminescence for a bioluminescence system containing a luciferase and luciferin, which comprises combining the compound of formula (I) or a salt thereof according to claim 1 with the bioluminescence system.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 30, 2010
From: FUJIMAKI, NOBUKO; NAKAGOMI, MADOKA; SHUDO, KOICHI
To: RESEARCH FOUNDATION ITSUU LABORATORY
Reel/Frame 025402/0330 →
Priority Claims (1)
JP 2008-047078 · Feb 28, 2008 · national
Continuity (1)
Related Publication 20110071304A1 · Mar 24, 2011